Cargando…
A 3-DNA methylation signature as a novel prognostic biomarker in patients with sarcoma by bioinformatics analysis
BACKGROUND: Tumor-specific DNA methylation can potentially be a useful indicator in cancer diagnostics and monitoring. Sarcomas comprise a heterogeneous group of mesenchymal neoplasms which cause life-threatening tumors occurring throughout the body. Therefore, potential molecular detection and prog...
Autores principales: | Wang, Xiao-Wei, Sun, Qi, Xu, Shi-Bin, Xu, Chao, Xia, Chen-Jie, Zhao, Qi-Ming, Zhang, Hua-Hui, Tan, Wei-Qiang, Zhang, Lei, Yao, Shu-Dong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8137010/ https://www.ncbi.nlm.nih.gov/pubmed/34011115 http://dx.doi.org/10.1097/MD.0000000000026040 |
Ejemplares similares
-
CCT6A, a novel prognostic biomarker for Ewing sarcoma
por: Jiang, Jie, et al.
Publicado: (2021) -
Identification of regulatory role of DNA methylation in colon cancer gene expression via systematic bioinformatics analysis
por: Yang, Yong, et al.
Publicado: (2017) -
BCL7B is a potential novel diagnosis and prognosis biomarker for sarcomas using bioinformatics analysis
por: Yang, Dinglong, et al.
Publicado: (2021) -
Identification of an eight-m6A RNA methylation regulator prognostic signature of uterine corpus endometrial carcinoma based on bioinformatics analysis
por: Miao, Chenyun, et al.
Publicado: (2021) -
Bioinformatics identification and validation of aging‑related molecular subtype and prognostic signature in breast cancer
por: Li, Jingtai, et al.
Publicado: (2023)